rs2303448
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000570175.1(ENSG00000261460):n.1151C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0604 in 1,552,948 control chromosomes in the GnomAD database, including 3,249 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.046 ( 224 hom., cov: 32)
Exomes 𝑓: 0.062 ( 3025 hom. )
Consequence
ENSG00000261460
ENST00000570175.1 non_coding_transcript_exon
ENST00000570175.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.50
Publications
5 publications found
Genes affected
HEXA (HGNC:4878): (hexosaminidase subunit alpha) This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
HEXA Gene-Disease associations (from GenCC):
- Tay-Sachs diseaseInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 15-72346371-C-T is Benign according to our data. Variant chr15-72346371-C-T is described in ClinVar as Benign. ClinVar VariationId is 256350.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.11 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HEXA | NM_000520.6 | c.1331-46G>A | intron_variant | Intron 11 of 13 | ENST00000268097.10 | NP_000511.2 | ||
| HEXA | NM_001318825.2 | c.1364-46G>A | intron_variant | Intron 11 of 13 | NP_001305754.1 | |||
| HEXA | NR_134869.3 | n.1116-46G>A | intron_variant | Intron 9 of 10 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HEXA | ENST00000268097.10 | c.1331-46G>A | intron_variant | Intron 11 of 13 | 1 | NM_000520.6 | ENSP00000268097.6 | |||
| ENSG00000260729 | ENST00000379915.4 | n.413-46G>A | intron_variant | Intron 3 of 15 | 2 | ENSP00000478716.1 |
Frequencies
GnomAD3 genomes AF: 0.0457 AC: 6951AN: 152120Hom.: 225 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
6951
AN:
152120
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0552 AC: 13624AN: 246764 AF XY: 0.0575 show subpopulations
GnomAD2 exomes
AF:
AC:
13624
AN:
246764
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0619 AC: 86774AN: 1400710Hom.: 3025 Cov.: 22 AF XY: 0.0627 AC XY: 43934AN XY: 700494 show subpopulations
GnomAD4 exome
AF:
AC:
86774
AN:
1400710
Hom.:
Cov.:
22
AF XY:
AC XY:
43934
AN XY:
700494
show subpopulations
African (AFR)
AF:
AC:
297
AN:
32354
American (AMR)
AF:
AC:
1297
AN:
44418
Ashkenazi Jewish (ASJ)
AF:
AC:
430
AN:
25692
East Asian (EAS)
AF:
AC:
5727
AN:
39384
South Asian (SAS)
AF:
AC:
5638
AN:
84848
European-Finnish (FIN)
AF:
AC:
2320
AN:
53308
Middle Eastern (MID)
AF:
AC:
367
AN:
5656
European-Non Finnish (NFE)
AF:
AC:
67581
AN:
1056732
Other (OTH)
AF:
AC:
3117
AN:
58318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
4336
8672
13007
17343
21679
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2460
4920
7380
9840
12300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0456 AC: 6947AN: 152238Hom.: 224 Cov.: 32 AF XY: 0.0447 AC XY: 3325AN XY: 74430 show subpopulations
GnomAD4 genome
AF:
AC:
6947
AN:
152238
Hom.:
Cov.:
32
AF XY:
AC XY:
3325
AN XY:
74430
show subpopulations
African (AFR)
AF:
AC:
461
AN:
41538
American (AMR)
AF:
AC:
437
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
69
AN:
3472
East Asian (EAS)
AF:
AC:
607
AN:
5176
South Asian (SAS)
AF:
AC:
304
AN:
4826
European-Finnish (FIN)
AF:
AC:
460
AN:
10616
Middle Eastern (MID)
AF:
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4349
AN:
68002
Other (OTH)
AF:
AC:
88
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
340
679
1019
1358
1698
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
247
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Tay-Sachs disease Benign:2
Apr 12, 2018
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.